Abstract
1064P Performance of low dose immunotherapy (IO) and standard dose IO in microsatellite-instability–high (MSI-H) metastatic colorectal cancer (mCRC): Real-world data
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have